Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the Horizon.
Journal of obesity & metabolic syndrome • Vol. 32, Issue 2 • 2023
Peptidyl and Non-Peptidyl Oral Glucagon-Like Peptide-1 Receptor Agonists.
Endocrinology and metabolism (Seoul, Korea) • Vol. 36, Issue 1 • 2021
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.
Proceedings of the National Academy of Sciences of the United States of America • Vol. 117, Issue 47 • 2020
Kinetic analysis of the individual reductive steps catalyzed by beta-hydroxy-beta-methylglutaryl-coenzyme A reductase obtained from yeast.
Biochemistry • Vol. 15, Issue 19 • 1976
